PENG nerve block with different steroid and sedative combinations for hip surgery in adults 65 and older
Official title: Comparison of Three Variants of PENG Block Using 20 mL of 0.2% Ropivacaine With Different Combinations of Dexamethasone and Perineural Dexmedetomidine in Patients Aged 65 Years and Older Undergoing Hip Surgery: A Randomized Controlled Trial.
Run by Poznan University of Medical Sciences · NCT07327931 · Data updated 2026-11-12
This trial will see if adding different combinations of dexamethasone and dexmedetomidine to a PENG nerve block gives adults 65 and older longer and better pain relief after hip surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years to 100 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Poznan University of Medical Sciences Academic / other |
| Locations | 1 site (Poznan) |
| Status | Recruiting |
| Started | February 13, 2026 |
| Main results expected | December 30, 2026 |
| Study ends | January 31, 2027 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT07327931 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 65 years or older scheduled for hip surgery who can give consent, are ASA I–III, and have no contraindication to regional anesthesia or the study medications.
✕Probably not a fit
Patients with active infection at the injection site, coagulopathy, severe hepatic or renal failure, pre-existing neuropathy, chronic daily opioid use, or allergy to ropivacaine, dexamethasone, or dexmedetomidine are unlikely to benefit or will be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized interventional study enrolls adults aged 65 and older undergoing elective or emergency hip surgery and compares three versions of the Pericapsular Nerve Group (PENG) block. All participants receive 20 mL of 0.2% ropivacaine, then are randomized to receive either intravenous dexamethasone, perineural dexmedetomidine plus intravenous dexamethasone, or both dexmedetomidine and dexamethasone given perineurally. Investigators will measure postoperative pain scores, opioid consumption, block duration, and functional recovery measures to determine which combination provides superior analgesia while preserving motor function. The trial excludes patients with coagulopathy, severe organ failure, pre-existing neuropathy, chronic opioid use, or contraindications to the study medications.
Why it matters
Potential benefit: If successful, the best combination could prolong nerve-block pain relief, reduce opioid use, and help older hip surgery patients recover and mobilize sooner.
How similar studies have gone: Prior trials and meta-analyses of peripheral nerve blocks indicate that dexamethasone and dexmedetomidine can prolong block duration, but evidence is limited specifically for PENG blocks and for the optimal routes and combinations in older adults.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 65 years or older * Scheduled for elective or emergency hip surgery (e.g., hip fracture fixation or hip arthroplasty) * ASA physical status I-III * Ability to communicate pain intensity using the NRS scale * Written informed consent obtained from the patient or legal representative * Planned use of PENG block as part of multimodal perioperative analgesia Exclusion Criteria: * Patient refusal or inability to provide informed consent * Allergy, intolerance, or contraindication to any study medication: ropivacaine, dexamethasone, dexmedetomidine * Pre-existing neurological deficit or neuropathy of the affected limb * Coagulopathy (INR \>1.5, platelets \<100,000/µL) or current therapeutic anticoagulation that contraindicates regional anesthesia * Infection at or near the injection site * Severe hepatic or renal impairment * History of chronic opioid use (daily opioids \>30 days before surgery) * Cognitive impairment or delirium precluding reliable pain assessment * BMI \> 40 kg/m² (if you want to exclude for technical difficulty) * Patients receiving another regional nerve block for hip surgery * Pregnancy or breastfeeding * Participation in another interventional clinical trial within 30 days
Where it's running
-
Poznan University of Medical Sciences
Poznan, Poland Recruiting
Study contacts
- Study coordinator: Malgorzata Reysner, MD PhD
- Email: mreysner@ump.edu.pl
- Phone: +48 61 873 83 03
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PENG block versus combined lumbar and sacral erector spinae plane (ESP) blocks for pain after total hip replacement
This trial will test whether the PENG nerve block or a combined lumbar-plus-sacral ESP block gives better pain relief and reduces opioid use in adults aged 65 and older having elective total hip replacement.
-
Comparing radiofrequency treatment and corticosteroid injection for hip osteoarthritis pain
This study is testing whether a new radiofrequency treatment works better than a steroid injection for relieving pain and improving movement in people with hip osteoarthritis.
-
Ceramic hip resurfacing vs total hip arthroplasty for hip OA
This trial tests whether ceramic hip resurfacing helps people with hip OA walk farther each day than a modern total hip replacement.
-
Dexmedetomidine during hip replacement to modulate nerves and inflammation
A randomized, placebo-controlled study tests whether intravenous dexmedetomidine given during spinal anesthesia with a PENG nerve block can help regulate the body's stress and inflammatory response and improve recovery after hip replacement.
-
Preoperative Fasting to Shape the Gut with Hip Replacement
This trial tests whether a 20-day preoperative fasting plan can lower inflammatory signals and broaden gut microbes in adults undergoing total hip arthroplasty.
-
Cryoneurolysis for Chronic Pain: 6- and 12-Month Outcomes in Routine Care
This study tests whether cryoneurolysis, done as part of standard care for people with chronic pain, leads to meaningful improvements over 6 to 12 months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.